169 related articles for article (PubMed ID: 38163157)
1. Bioinformatics reveals diagnostic potential of cuproptosis-related genes in the pathogenesis of sepsis.
Sun Z; Zhao Q; Zhang J; Hu Y; Qu J; Gao H; Peng Z
Heliyon; 2024 Jan; 10(1):e22664. PubMed ID: 38163157
[TBL] [Abstract][Full Text] [Related]
2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
3. Investigating hub genes in the relationship between septic cardiomyopathy and cuproptosis and potential Chinese herbal drug candidates with bioinformatic tools.
Pang G; Hu K; Ji J; Xiong B; Han L; Pang J; Xiang S
Minerva Cardiol Angiol; 2024 May; ():. PubMed ID: 38804624
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
Chen Y
Front Genet; 2022; 13():912037. PubMed ID: 35937995
[No Abstract] [Full Text] [Related]
5. Exploring the role of LIAS-related cuproptosis in systemic lupus erythematosus.
Li Y; Xu B; Zhang J; Liu X; Ganesan K; Shi G
Lupus; 2023 Dec; 32(14):1598-1609. PubMed ID: 37903189
[TBL] [Abstract][Full Text] [Related]
6. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia.
Li Y; Kan X
Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332
[TBL] [Abstract][Full Text] [Related]
7. Cuproptosis-Related 4-Gene Risk Model for Predicting Immunotherapy Drug Response and Prognosis of Kidney Renal Clear Cell Carcinoma.
Guo JS; Ding H; Wu PY; Xin ZY; Li JX; Jo HS; Ma ZH
Chin Med Sci J; 2023 Sep; 38(3):191-205. PubMed ID: 37503721
[TBL] [Abstract][Full Text] [Related]
8. Identification of hub cuproptosis related genes and immune cell infiltration characteristics in periodontitis.
Liu S; Ge J; Chu Y; Cai S; Wu J; Gong A; Zhang J
Front Immunol; 2023; 14():1164667. PubMed ID: 37215133
[TBL] [Abstract][Full Text] [Related]
9. Regulation, genomics, and clinical characteristics of cuproptosis regulators in pan-cancer.
Zhou C; Li C; Zheng Y; Huang X
Front Oncol; 2022; 12():934076. PubMed ID: 36387247
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of cuproptosis genes and cuproptosis-related genes as prognosis factors in esophageal squamous cell carcinoma.
Wu Z; Huang Z; Zhou X; Gao C; Peng Z; Zheng X; Zhang Y; Du Z; Wu B
Genomics; 2023 Nov; 115(6):110732. PubMed ID: 37866660
[TBL] [Abstract][Full Text] [Related]
11. Identification of Cuproptosis-Related Genes in Nonalcoholic Fatty Liver Disease.
Wu C; Liu X; Zhong L; Zhou Y; Long L; Yi T; Chen S; Li Y; Chen Y; Shen L; Zeng Q; Tang S
Oxid Med Cell Longev; 2023; 2023():9245667. PubMed ID: 36865349
[TBL] [Abstract][Full Text] [Related]
12. Verification of cuproptosis-related diagnostic model associated with immune infiltration in rheumatoid arthritis.
Jiang M; Liu K; Lu S; Qiu Y; Zou X; Zhang K; Chen C; Jike Y; Xie M; Dai Y; Bo Z
Front Endocrinol (Lausanne); 2023; 14():1204926. PubMed ID: 37547319
[TBL] [Abstract][Full Text] [Related]
13. Novel cuproptosis-related prognostic gene profiles in preeclampsia.
Tang X; Liu Y; Zhang Y
BMC Pregnancy Childbirth; 2024 Jan; 24(1):53. PubMed ID: 38200445
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning.
Ouyang G; Wu Z; Liu Z; Pan G; Wang Y; Liu J; Guo J; Liu T; Huang G; Zeng Y; Wei Z; He S; Yuan G
Front Immunol; 2023; 14():1251750. PubMed ID: 37822923
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a cuproptosis-related signature to evaluate immune features and predict prognosis in colorectal cancer.
Li L; Sun F; Kong F; Feng Y; Song Y; Du Y; Liu F; Kong X
Front Oncol; 2023; 13():1083956. PubMed ID: 37384293
[TBL] [Abstract][Full Text] [Related]
16. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
[TBL] [Abstract][Full Text] [Related]
17. Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction.
Liu Z; Wang L; Xing Q; Liu X; Hu Y; Li W; Yan Q; Liu R; Huang N
Front Cardiovasc Med; 2022; 9():1016081. PubMed ID: 36440046
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma.
Wang S; Xing N; Meng X; Xiang L; Zhang Y
Front Pharmacol; 2022; 13():971867. PubMed ID: 36110528
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive analysis and validation of cuproptosis-associated genes across cancers: Overall survival, the tumor microenvironment, stemness scores, and drug sensitivity.
Liu J; Lu Y; Dai Y; Shen Y; Zeng C; Liu X; Yu H; Deng J; Lu W
Front Genet; 2022; 13():939956. PubMed ID: 36105090
[No Abstract] [Full Text] [Related]
20. Characterization of cuproptosis identified immune microenvironment and prognosis in acute myeloid leukemia.
Luo D; Liu S; Luo J; Chen H; He Z; Gao Z; Wen Z; Liu X; Xu N
Clin Transl Oncol; 2023 Aug; 25(8):2393-2407. PubMed ID: 36826709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
